After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NUVB belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. The current market capitalization of Nuvation Bio Inc is $738.37M. A total of 3.28 million shares were traded on the day, compared to an average of 3.00M shares.
In the most recent transaction, Liu Dongfang sold 20,000 shares of NUVB for 2.50 per share on May 02 ’25. After the transaction, the CHIEF MEDICAL OFFICER now owns 12,000 company shares. In a previous transaction on May 02 ’25, DONGFANG LIU bought 20,000 shares at 2.27 per share.
Among the insiders who bought shares, Hung David acquired of 300,000 shares on Apr 07 ’25 at a per-share price of $1.62. This resulted in the PRESIDENT AND CEO holding 58,781,054 shares of NUVB after the transaction. In another insider transaction, Hung David bought 200,000 shares at $1.66 per share on Apr 04 ’25. Company shares held by the PRESIDENT AND CEO now total 58,481,054.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NUVB has a high of $3.97 and a low of $1.54.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NUVB’s latest balance sheet shows that the firm has $765.39M in Cash & Short Term Investments as of fiscal 2021. There were $3.06M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $1.23, while its Total Shareholder’s Equity was $746.00M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUVB is Buy with a score of 4.86.
